Cargando…
Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Background: Cisplatin-based combination chemotherapy is standard treatment for metastatic urothelial carcinoma; however, the vast majority of patients experience disease progression. As systemic therapy alone is rarely curative for the treatment of metastatic urothelial cancer, not only are new ther...
Autores principales: | Patel, Vaibhav, Collazo Lorduy, Ana, Stern, Aaron, Fahmy, Omar, Pinotti, Rachel, Galsky, Matthew D., Gakis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409038/ https://www.ncbi.nlm.nih.gov/pubmed/28516157 http://dx.doi.org/10.3233/BLC-170108 |
Ejemplares similares
-
Metastasectomy could not improve the survival of metastatic urothelial carcinoma: evidence from a meta-analysis
por: Xing, Qianwei, et al.
Publicado: (2020) -
Long-term survival of a patient with pulmonary metastatic urothelial carcinoma following metastasectomy
por: Hasebe, Kenichi, et al.
Publicado: (2018) -
Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder Cancer
por: Gakis, Georgios, et al.
Publicado: (2016) -
Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer
por: Yang, Seung Wook, et al.
Publicado: (2013) -
Metastasectomy of oligometastatic urothelial cancer: a single-center experience
por: Muilwijk, Tim, et al.
Publicado: (2020)